Amwell® to participate in upcoming investor conferences

BOSTON, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Amwell^® (NYSE: AMWL), a leading provider of technology enabled care, today announced that members of the Amwell management team will participate in the following upcoming investor conferences:

• Wells Fargo 21st Annual Healthcare Conference, on Wednesday, September 9, 2026, in Boston, MA. Mark Hirschhorn, CFO and COO, will represent the Company.
• Morgan Stanley 24th Annual Global Healthcare Conference, on Wednesday, September 16, 2026, along with an in-person fireside chat from 1:05 p.m. to 1:40 p.m. ET, in New York, NY. Mark Hirschhorn, CFO and COO, will represent the Company.
  
  

Details regarding audio webcasts, where available, will be posted on the Company's investor relations website at https://investors.amwell.com.

About Amwell

Amwell offers health plans and healthcare organizations a single, comprehensive, technology-enabled care platform. We use technology to provide consumers with better access to more convenient, affordable, and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows consumers to experience unified, personalized, and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions while delivering dependable outcomes. For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Media Contact

Press inquiries:
[email protected]

Investor contact:
Asher Dewhurst
[email protected]

You May Also Be Interested In

• MAK Acquisition Delivers Notice of Breach to UniUni
• Prime Drink Group Provides Bi-Weekly MCTO Status Report
• 22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule